Skip to content
TrialScanner

NCT06206811

Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants

Phase 1CompletedODTXLead

Registry record

Lead sponsor
Odyssey Therapeutics, Inc.
Conditions
Inflammatory Bowel Diseases; Blau Syndrome; Crohn Disease; Ulcerative Colitis; Spondyloarthritis
Primary completion
Nov 25, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06206811 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06206811: Phase 1 Study to Investigate... | TrialScanner